TWI844795B - 自噬活化劑 - Google Patents
自噬活化劑 Download PDFInfo
- Publication number
- TWI844795B TWI844795B TW110134884A TW110134884A TWI844795B TW I844795 B TWI844795 B TW I844795B TW 110134884 A TW110134884 A TW 110134884A TW 110134884 A TW110134884 A TW 110134884A TW I844795 B TWI844795 B TW I844795B
- Authority
- TW
- Taiwan
- Prior art keywords
- gene
- autophagy
- tocopherol
- tocopherol phosphate
- disease
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Birds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020156458 | 2020-09-17 | ||
| JP2020-156458 | 2020-09-17 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW202228715A TW202228715A (zh) | 2022-08-01 |
| TWI844795B true TWI844795B (zh) | 2024-06-11 |
Family
ID=80776075
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW110134884A TWI844795B (zh) | 2020-09-17 | 2021-09-17 | 自噬活化劑 |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JPWO2022059767A1 (https=) |
| KR (1) | KR20230051262A (https=) |
| CN (1) | CN116507314A (https=) |
| TW (1) | TWI844795B (https=) |
| WO (1) | WO2022059767A1 (https=) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1723019A (zh) * | 2003-01-17 | 2006-01-18 | 生命健康科学有限公司 | 具有抗增殖属性的化合物 |
| WO2020090881A1 (ja) * | 2018-11-02 | 2020-05-07 | 昭和電工株式会社 | 水中油滴型皮膚外用剤 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1589964B1 (en) * | 2003-01-17 | 2011-11-23 | Vital Health Sciences Pty Ltd. | Compounds having anti-proliferative properties |
| WO2013018779A1 (ja) | 2011-08-01 | 2013-02-07 | 株式会社林原 | α-グルコシルヘスペリジンの結晶とその用途 |
| KR20170141705A (ko) | 2015-04-08 | 2017-12-26 | 바이오멘딕스, 엘엘씨 | 상처 치유를 조절하기 위한 제형 및 방법 |
| JP6740354B2 (ja) | 2015-10-05 | 2020-08-12 | ザ トラスティーズ オブ コロンビア ユニバーシティー イン ザ シティー オブ ニューヨーク | オートファジーの流れ及びホスホリパーゼd及びタウを含むタンパク質凝集体のクリアランスの活性化剤ならびにタンパク質症の治療方法 |
| JP7136765B2 (ja) | 2017-03-24 | 2022-09-13 | 株式会社林原 | オートファジー誘導剤とその用途 |
| JP7399406B2 (ja) * | 2019-03-04 | 2023-12-18 | 公立大学法人横浜市立大学 | 精子形成誘導用培地 |
| JP7497850B2 (ja) * | 2019-12-23 | 2024-06-11 | 株式会社アイ・ティー・オー | 細胞送達用キャリア |
-
2021
- 2021-09-17 CN CN202180075908.7A patent/CN116507314A/zh active Pending
- 2021-09-17 TW TW110134884A patent/TWI844795B/zh active
- 2021-09-17 JP JP2022550624A patent/JPWO2022059767A1/ja active Pending
- 2021-09-17 KR KR1020237008830A patent/KR20230051262A/ko active Pending
- 2021-09-17 WO PCT/JP2021/034243 patent/WO2022059767A1/ja not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1723019A (zh) * | 2003-01-17 | 2006-01-18 | 生命健康科学有限公司 | 具有抗增殖属性的化合物 |
| WO2020090881A1 (ja) * | 2018-11-02 | 2020-05-07 | 昭和電工株式会社 | 水中油滴型皮膚外用剤 |
Non-Patent Citations (1)
| Title |
|---|
| 期刊 , A GUGLIANDOLO, et al., "α-Tocopherol modulates non-amyloidogenic pathway and autophagy in an in vitro model of Alzheimer's disease: A transcriptional study", Brain Sci., 9, MDPI, 2019: 196. * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022059767A1 (ja) | 2022-03-24 |
| JPWO2022059767A1 (https=) | 2022-03-24 |
| KR20230051262A (ko) | 2023-04-17 |
| CN116507314A (zh) | 2023-07-28 |
| TW202228715A (zh) | 2022-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011246442A (ja) | 光老化抑制剤および皮膚菲薄化抑制剤 | |
| CN1984637A (zh) | 包含芍药甙的皮肤老化护理品 | |
| JP5893013B2 (ja) | 光曝露による皮膚細胞異常化の抑制剤 | |
| TWI844795B (zh) | 自噬活化劑 | |
| JP2005535717A (ja) | フィトスフィンゴシン誘導体を含むアポトーシス誘導用組成物 | |
| JP7619529B2 (ja) | 水系組成物、及び皮膚外用剤 | |
| JP7361448B2 (ja) | トランスグルタミナーゼ発現促進剤 | |
| CN116322705B (zh) | 自噬激活剂 | |
| WO2008041608A1 (fr) | Préparation externe cutanée et produit de soin capillaire | |
| CN116782910A (zh) | 屏障功能改善剂 | |
| TW202228676A (zh) | 自噬活化劑 | |
| JP6368219B2 (ja) | エストロゲン受容体β活性化剤 | |
| JPWO2022168846A5 (https=) | ||
| JP2022119110A (ja) | バリア機能改善剤 | |
| JP2017088559A (ja) | フィラグリン産生促進剤 | |
| US20230364119A1 (en) | Autophagy activator | |
| WO2014073646A1 (ja) | シコニン誘導体を有するペリオスチンの発現抑制剤 | |
| KR101984276B1 (ko) | 베르베린 하이드로클로라이드를 유효성분으로 포함하는 체모성장 저해용 조성물 | |
| WO2020230726A1 (ja) | 大気汚染物質からの保護剤及び大気汚染物質からの保護用組成物 | |
| JP2020193182A (ja) | 糖化反応抑止剤 | |
| WO2025094676A1 (ja) | 1-ピペリジンプロピオン酸とゲンノショウコとを含む組成物 | |
| KR20160133044A (ko) | 클로린 e6을 포함하는 아토피 피부염 예방 및 치료용 조성물 | |
| KR20250089445A (ko) | Yap 억제제를 유효성분으로 포함하는 아토피성 피부염의 예방 또는 치료용 약학 조성물 | |
| KR20150051075A (ko) | 팔마틴을 유효성분으로 포함하는 체모성장 저해용 조성물 | |
| CN115297866A (zh) | 变性弹性蛋白的分解降低的抑制剂、正常的弹性蛋白纤维的维持剂、弹性蛋白-抑弹性蛋白酶蛋白复合体形成抑制剂及含有这些的组合物 |